Home
|
Publications
|
The Novo Group
|
Contact
About Novo
Charter
Novo's Mission
The team
Novo Seeds
Novo Ventures
Novo Growth Equity
Novo Finance
Careers
News archive
2012 -
2011
-
2010
-
2009
-
2008
-
2007
-
2006
-
2005
-
2004
-
2003
31-01-2012
Orexo's drug discovery collaboration terminated and OX-CLI/OX-ESI projects end
11-01-2012
Novo A/S acquires 25.66% of the shares in Chr. Hansen A/S
09-01-2012
AnaptysBio announces new strategic antibody discovery alliances with two pharma partners
06-01-2012
AlloCure’s Investigational Treatment for Acute Kidney Injury Receives Fast Track Designation by FDA
06-01-2012
Reata Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
05-01-2012
Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy
04-01-2012
Veloxis Pharmaceuticals Announces Initiation of STRATO Study of LCP-Tacro™ in Kidney Transplant Recipients Experiencing Tremors
© Novo A/S 2010
Disclaimer
|
Sitemap